Mineralys Therapeutics, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €24.33M
    R&D expenses
    €149.90M
    EBITDA
    -€174.21M
    D&A
    €22.31K
    EBIT
    -€174.23M
    Interest expenses
    €0.00
    EBT
    -€163.68M
    Tax expenses
    €0.00
    Net income
    -€163.68M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €26.47M
    Changes in working capital
    -€37.08M
    Operating cash flow
    -€165.32M
    Capex
    €31.75K
    Other investing cash flow
    €0.00
    Net investing cash flow
    €23.52M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €162.06M
    Debt repayment
    €0.00
    Other financing cash flow
    €8.61M
    Net financing cash flow
    €170.91M
    Foreign exchange effects
    €0.00
    Net change in cash
    €29.11M
    Cash at end of period
    €87.33M
    Free cash flow
    -€165.29M

    Balance sheet

    Cash and cash equivalents
    €87.33M
    Cash and short-term investments
    €87.33M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €200.33M
    Total current assets
    €287.66M
    Property, plant & equipment
    €18.88K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €371.51K
    Total non-current assets
    €390.39K
    Total assets
    €288.05M
    Accounts payable
    €2.71M
    Short-term debt
    €0.00
    Other current liabilities
    €16.31M
    Total current liabilities
    €19.02M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €19.02M
    Common stock
    €5.15K
    Retained earnings
    -€332.91M
    Other equity
    €0.00
    Total equity
    €269.03M
    Total liabilities and shareholders' equity
    €288.05M

    Company information

    Market capitalization
    €762.16M
    Employees
    51
    Enterprise Value
    €848.47M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -60.8%
    ROA
    -56.8%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -21.7%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€3.21M

    Notifications